Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

Abr 10, 2024 | Uncategorized

Transaction would give the pharmaceutical giant access to Alpine’s potential treatment for chronic kidney disease.

Translate »
Contactar
1
Scan the code
Hola👋
¿Cómo podemos ayudarte?